Selecting a contract manufacturer is one of the most consequential decisions for any supplement brand. Polished sales presentations and third-party GMP certificates confirm that a facility has been inspected, but they do not tell you how consistently that facility will test, document, and control your specific product under FDA's 21 CFR Part 111 cGMP regulations.
A focused qualification audit evaluates raw material identity testing (21 CFR § 111.75), Master Manufacturing Records and Batch Production Records, cross-contamination controls, sanitation practices, and laboratory method suitability. Because FDA holds the brand owner responsible for the finished product introduced into interstate commerce, gaps at the contract manufacturer become the brand's regulatory and commercial risk.
Blue Ocean Regulatory conducts independent desktop and on-site audits of contract manufacturers on behalf of brand owners. We evaluate facilities against 21 CFR Part 111 requirements, food safety practices, and the specific analytical and operational demands of your formula, delivering a clear report of findings and corrective action priorities.
For example, when an audit of a certified facility identifies a material-handling or cross-contact gap that affects sensitive formulas (such as prenatal or allergen-free supplements), the brand can require targeted corrective controls, add lot-specific verification testing to the finished-product specification, or qualify a secondary manufacturer before a problem reaches consumers.
Independent qualification before you commit to full-scale production gives you the evidence needed to hold your manufacturing partner accountable.